Valerie DeBenedette is managing editor of Drug Topics.
Rheumatology, the journal of the British Society for Rheumatology, is offering free access (through December 31) to its ten most highly cited papers of 2017 and 2018. In this slideshow, we highlight the 10 most cited articles.
Rheumatology, the journal of the British Society for Rheumatology, is offering free access (through December 31) to its ten most highly cited papers of 2017 and 2018. In this slideshow, we highlight the 10 most cited articles.
“The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies.” Aug. 9, 2017. https://doi.org/10.1093/rheumatology/kex260
“The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.” April 4, 2017. https://doi.org/10.1093/rheumatology/kex260
"Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study." November 2017. https://doi.org/10.1093/rheumatology/kex301.
"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults." July 2018. https://doi.org/10.1093/rheumatology/kew399.
"The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus." April 2017. https://doi.org/10.1093/rheumatology/kex286
"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies." June 2017. https://doi.org/10.1093/rheumatology/kex021
"Nicotine drives neutrophil extracellular traps formation and accelerates collagen-induced arthritis." April 2017. https://doi.org/10.1093/rheumatology/kew449
"What drives osteoarthritis?-synovial versus subchondral bone pathology." September 2017. https://doi.org/10.1093/rheumatology/kew389
"The British Society for Rheumatology Guideline for the Management of Gout." July 2017. https://doi.org/10.1093/rheumatology/kex156
"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy." May 2017. https://doi.org/10.1093/rheumatology/kew470
